Smiths Medical announces that its ViaValve Safety I.V. Catheter has been cleared by the Food and Drug Administration (FDA) and can be marketed in the United States. The ViaValve catheter is designed to enhance clinician and patient safety by helping reduce the risk of both blood exposure and needlestick injury and will be available for sale by the end of summer 2012.
The ViaValve Safety I.V. Catheter can help reduce the risk of blood exposure by means of an integrated valve in the catheter hub. The valve provides blood control by impeding the backflow of blood from the patients vein upon initial venipuncture. This helps to prevent the transfer of bloodborne pathogens from patient to caregiver on soiled gloves, clothing, bedding and dressings by maintaining a clean access site. ViaValve Safety I.V. Catheter also helps prevent inadvertent needlesticks, which, each year, affect approximately 800,000 hospital-based healthcare workers in the U.S.
For nearly 20 years, Smiths Medicals Jelco® safety I.V. catheters have provided needlestick protection consistent with legislation driven by the U.S. Needlestick Safety and Prevention ACT and OSHAs bloodborne pathogens standards (29 CFR 1910.1030). FDA 510(k) clearance of ViaValve Safety I.V. Catheter will allow the company to market a catheter that could help advance I.V. catheter safety by establishing an even higher standard of safety with requirements for blood control.
We are pleased to add a solution that helps to reduce bloodborne infections during I.V. starts, says Tommy Johns, vice president of global product management. The ViaValve Safety I.V. Catheter is the latest advancement in I.V. safety, and is built on the proven Jelco® catheter platform that has been a favorite of clinicians for almost two decades. It is our objective to produce innovative medical products with the purpose of promoting patient, clinician and healthcare worker safety while supporting the best possible clinical outcome.
Product(s) described may not be licensed or available for sale in all countries. The ViaValve catheter is FDA 510(k) cleared in the U.S.
Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.